Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Country's Decision or any other Communication
(DEC)
last updated: 12 Jun 2014
No
Resolución 1250: Por la cual se autoriza el uso (importación y comercialización) a la empresa intervet Colombia LTDA del producto INNOVAX ND SB, vacuna aviar para la enfermedad de Marek y la enfermedad de Newcastle serotipos 2 y 3 virus vivo, vector vivo de la enfermedad de Marek.
ES
09 Apr 2010
No
- Decision on Pharmaceuticals (Article 5)
-
BCH-LMO-SCBD-105091-1 Living Modified Organism INNOVAX® ND VaccineIntervet do Brasil Veterinária Ltda(INTERVET) | Production of medical or pharmaceutical compounds (human or animal) (Vaccines)
-
BCH-RA-CO-105609-2 Risk Assessment generated by a regulatory process Uso del producto INNOVAX ND SB, vacuna aviar para la enfermedad de Marek y la enfermedad de Newcastle serotipos 2 y 3 virus vivo, vector vivo de la enfermedad de Marek.INNOVAX® ND Vaccine | Production of medical or pharmaceutical compounds (human or animal)
- Res 1250 de 2010 INNOVAX ND SB.pdf [ Spanish ]
